Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor
- PMID: 7997239
- DOI: 10.1210/mend.8.8.7997239
Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor
Abstract
Inhibin-alpha-deficient mutant mice have been generated by a targeted deletion of the inhibin-alpha gene through homologous recombination in murine embryonic stem cells. Essentially all of the homozygous mutants develop gonadal sex cord-stromal tumors. To investigate their endocrine and proliferative characteristics, gonadal tumor cells were maintained in vitro. Cells from inhibin-alpha-deficient mice multiplied poorly; however, cells from mice deficient in both inhibin-alpha and p53 proliferated rapidly and showed higher saturation density and plating efficiency, thus allowing the establishment of clonal tumor cell lines. Although negligible estrogen and testosterone was produced by the clonal cells, high levels of progesterone were secreted. A clonal testis tumor cell line (inhibin-alpha/p53 deficient) showed no response to exogenous FSH, human CG (hCG), or inhibin A but exhibited a 6- to 8-fold increase in progesterone production in response to forskolin treatment. The stimulatory effect of forskolin was, however, partially blocked by activin treatment. Northern blot analysis revealed inhibin beta A and beta B mRNA expression in these cells. Furthermore, Western blot analyses indicated the secretion of the beta A-subunit protein. We further tested the role of activin on tumor cell growth. Treatment with follistatin, an activin-binding protein, inhibited tumor cell replication in a dose-dependent manner. In contrast, treatment with activin A stimulated tumor cell growth by itself and partially blocked follistatin action. Incorporation of thymidine into DNA of these cells was also stimulated by activin. In addition, treatment with antiactivin A serum inhibited tumor cell replication and blocked the stimulatory action of activin on cell growth. The activin action is likely mediated by specific receptors because cross-linking of [125]activin to the 50-55 kilodalton type I and 75-80 kilodalton type II receptors was found using sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis. Northern blot analysis also revealed follistatin mRNA expression in the tumor cells, suggesting these cells are related to granulosa cells. Our findings indicate that activin can act as an autocrine growth factor in stimulating the proliferation of gonadal tumor cell lines derived from inhibin-alpha and p53-deficient mice and inhibits progesterone production. These tumor cell lines are useful for studies on the regulation of gonadal cell proliferation and steroidogenesis as well as the signaling pathway mediating activin action.
Similar articles
-
Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.Endocrinology. 2000 Jul;141(7):2319-27. doi: 10.1210/endo.141.7.7535. Endocrinology. 2000. PMID: 10875231
-
Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.Endocrinology. 1996 Feb;137(2):486-94. doi: 10.1210/endo.137.2.8593793. Endocrinology. 1996. PMID: 8593793
-
Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.Mol Endocrinol. 1996 May;10(5):534-43. doi: 10.1210/mend.10.5.8732684. Mol Endocrinol. 1996. PMID: 8732684
-
Inhibins, activins and follistatins.J Steroid Biochem. 1989 Oct;33(4B):705-13. J Steroid Biochem. 1989. PMID: 2689779 Review.
-
Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.Recent Prog Horm Res. 1996;51:123-54; discussion 155-7. Recent Prog Horm Res. 1996. PMID: 8701077 Review.
Cited by
-
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy.Clin Cancer Res. 2023 May 15;29(10):1969-1983. doi: 10.1158/1078-0432.CCR-22-2254. Clin Cancer Res. 2023. PMID: 36795892 Free PMC article.
-
Lentivirus-Mediated Short Hairpin RNA for Follistatin Downregulation Suppresses Tumor Progression in Hypopharyngeal Carcinoma.Curr Med Sci. 2022 Aug;42(4):832-840. doi: 10.1007/s11596-022-2615-3. Epub 2022 Jul 21. Curr Med Sci. 2022. PMID: 35864413
-
Clinical and Therapeutic Implications of Follistatin in Solid Tumours.Cancer Genomics Proteomics. 2016 11-12;13(6):425-435. doi: 10.21873/cgp.20005. Cancer Genomics Proteomics. 2016. PMID: 27807065 Free PMC article. Review.
-
Gene expression profiling reveals Cyp26b1 to be an activin regulated gene involved in ovarian granulosa cell proliferation.Endocrinology. 2011 Jan;152(1):303-12. doi: 10.1210/en.2010-0749. Epub 2010 Nov 17. Endocrinology. 2011. PMID: 21084447 Free PMC article.
-
Activin-A in myometrium: characterization of the actions on myometrial cells.Endocrinology. 2008 May;149(5):2506-16. doi: 10.1210/en.2007-0692. Epub 2008 Jan 31. Endocrinology. 2008. PMID: 18239071 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous